Maternal Adverse Childhood Experiences Linked to Changes in Neonatal Brain Development and Behavior
Maternal ACEs were associated with both newborn amygdala volume and subsequent infant negative emotionality.
Maternal ACEs were associated with both newborn amygdala volume and subsequent infant negative emotionality.
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on clinical issues regarding prescribing antidepressants during pregnancy with Ob.Gyn News on August 16, [...]
A recent study shows the OCRDs, especially those that are more body-focused, have the potential to emerge or worsen during pregnancy and the postpartum, leading to high levels of comorbid depression and functional impairment.
More infants who were exposed to strong agonists and opioids with long half-lives, including methadone, developed neonatal opioid withdrawal syndrome.
Prenatal cannabis exposure was associated with persisting vulnerability to psychopathology throughout early adolescence.
Family history of psychiatric illness was associated a twofold increased risk for postpartum depression.
Every week, there are so many important and interesting articles related to the care of women. While these articles may not fall under the umbrella of reproductive psychiatry, much of this information affects the women we care for.
The FDA accepted a New Drug Application for fezolinetant, a novel, nonhormonal selective neurokinin-3 receptor (NK3R) antagonist for the treatment of menopause-related vasomotor symptoms.
Despite the unequivocal benefits of folic acid supplementation and recommendations urging all women of reproductive age to take folic acid supplements, preconceptual use of folic acid has not increased substantially.
Every week we review the most recent publications in women’s mental health.